Growth Factors (Blood and Tissue)
A World Report
| Product Code | BIZ00130 |
| Publication Date | November 2009 |
| Publisher | BizAcumen |
| Product Type | Report |
| Pages | 378 |
| ISBN Number | not applicable |
Growth Factors (Blood and Tissue)
A World Report
Age-related conditions such as Alzheimer's disease, malignancies, trauma and autoimmune disorders necessitate the development of less-invasive and more effective therapies. Growth factors (blood and tissue) have made an indelible mark on the market as a promising and cost-effective therapeutic solution for addressing unmet medical needs. Growth factors have a wide range of opportunities, especially in treating critical conditions such as granulocytopenia, leukemia, aplastic anaemia, bone marrow transplantation, and myelodysplastic syndrome. Additionally, human recombinant technologies have triggered these therapeutic biological products to greater heights.
These and other market data and trends are presented in "Growth Factors ( Blood And Tissue ): A World Report" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
Contents
- 1.Methodology
- Study Reliability and Reporting Limitations
- Disclaimers
- Quantitative Techniques & Reporting Level
- 2.Introduction
- Growth Factors: A Preface
- Growth Factors: Their Role and Related Applications
- Growth Factors: Adding A New Dimension
- Growth Factors: Classification Based on Activity
- Recent Trends & Developments
- Recombinant Human Erythropoietin: Gradually Gaining Dominance
- 3.Market Overview
- Epo - The Lead 'factor'
- Leading Epo Drugs Worldwide
- Market Comparison of Erythropoietin-Based Drugs in America and European Union: Classification Based on Key Parameters
- Patent Expiries of Major Biopharmaceutical Drugs
- 4.Market Dynamics
- Dethroning The Leaders
- Expiration of Patents Fuels Competition and Sales
- India - at The Center Stage...
- Side Effects - Still A Concern...
- Cder- A Regulatory Review Authority for Growth Factors
- 5.Outlook
- Innovative Delivery System Shows Potential for Accelerating Use of Growth Factors
- Cytokines - Vital Growth Propellers for The Future of New Drugs
- Brain Derived Neurotrophic Factor (Bdnf) Finds Increased Application
- Age-Related Diseases - Their Influence on Effective Therapies
- Copaxone Finds Novel Applications
- Mimetic Growth Factors - Exhibiting Promising Potential
- 6.Industry Issues
- Development of Cost Effective Methods - Need of The Hour
- Influence of Neurotrophic Factors on Brain Cell Development
- Combination of Interferons and Ribavirin Develops More Anemia Cases
- 7.Competitive Trends
- Regenerx Focuses on Wound Healing Market
- Drl Introduces A Program to Propel Its Biogenerics Business
- 8.Product Facts
- Blood Growth Factors
- Erythropoietins
- Colony Stimulating Factors
- Interferons
- Types of Interferons
- Interleukins
- Types of Interleukins
- Tissue Growth Factors
- Tissue Growth Factors: Classification Based on Key Source and Principal Activity
- Growth Factors: Application by Compound and Supplier
- Growth Factors: Indicated Applications by Site/Course of Action
- 9.Research and Development Highlights
- Maxygen Updates on Factor Vii Program
- Evaluation of Extended Dosing Schedule of Procrit®
- Procrit® - A Better Option
- Nerve Growth Factor Shows Promising Potential against Diabetes
- Cytokines and Gm-Csf Found to Be Closely Interlinked
- Gm-Csf Enhances Rate of Survival in Neonates
- Rg-Csf Well Tolerated in Pneumonia and Severe Sepsis Patients
- Rg-Csf- Their Influence on Preterm Infants with Sepsis
- Serum Macrophage Colony Stimulating Growth Factors Associated with Thrombocyte and Monocyte
- Src Pathway Inactivation in Kit Impairs Blood Cell Growth and Proliferation
- Cole Eye Institute Offers Timp-3 Mechanism for Preventing Abnormal Growth of Blood Vessels
- Effect of Brain Derived Neurotrophic Factor on Retinal Cells
- Orcel™ Exhibits High Growth Factor for Wound Healing and Cardiovascular Applications
- Drug Combination of Macrophage Colony Stimulating Factor Shows Successful Tolerance Levels
- Neotrofin™ Triggers Neurotrophic Factors
- G-Csf Shows Capability for Promoting Neutrophil Production
- Insulin-like Growth Factor-1 (Igf) Gene Transfer Accelerates Wound Healing Process
- Hepatocyte Growth Factors - Exhibiting Dual Role
- Cortex Pharmaceuticals Ampakines® Promotes Expression of Neurotrophin
- Granulocyte Colony Stimulating Factor Finds Application in Treating Neonates
- Cerebrolysin Promotes Cognition
- 10.Breakthroughs - A Review
- Novel Set of Human Cytokines Unveiled
- Igfbp-3 and Its Potential to Ward off Gastric Cancer
- Bone Morphogenic Proteins Show Potential for Musculoskeletal Regeneration
- Growth Factors - Their Role in Preventing Heart Stroke
- Growth Factor Proteins Shows Promising Results for Treating Cancer
- Neurotrophic Growth Factor Primarily Responsible for Loss of Vision
- Redox-Active Grape Seed Exhibits Favorable Properties for Dermal Wound Healing
- Role of Brain-Derived Neurotrophic Factor on Memory
- Nerve Growth Factor Found to Enhance Barium Current and Insulin Secretion
- Lipid Peroxidation May Be Associated with Wound Healing
- Genentech Inc Unveils Molecule for Stimulating Growth of Blood Vessels
- Connective Tissue Growth Factor Found to Promote Lung Fibroblast
- Influence of Insulin-like Growth Factor on Growth
- Regeneron Discovers Angiopoietins Targeted at Blood Vessel Growth and Repair
- Environment and Insulin-like Growth Factors Stimulate Risk of Cancer
- Cocktail of Neurotrophic Factors Promotes Regeneration of Torn Nerves
- Growth Factors Administration to Stimulate Tissue Repair
- Cytokine - Their Role in Combating Hepatitis C Virus
- Axokine® Yields Favorable Results against Obesity
- Cell Genesys Unveils Gdnf Gene Therapy Targeted against Parkinson's Disease
- 11.Corporate Developments
- Pfizer Inks Exclusive Global Licensing Agreement with Scil Technology
- Zgen Initiates Ph Ii Trial of Interleukin 21
- Fziomed Bags Health Canada Approval on Oxiplex®
- Nsgene A/S Implants Encapsulated Cell in Patients
- Reliance Life Sciences Takes over Genemedix
- Fraunhofer Institute Introduces First Interferon Beta 1a to Treat Multiple Sclerosis
- Shanghai Wanxing Inks Export Deal for Recombinant Human Interferon
- Hemispherx Enters into Distribution Agreement with Armada
- Bayer Launches US Pharmaceuticals Subsidiary
- Merck Inks Agreement with Bristol-Myers Squibb and Imclone
- Cogenesys Signs Global Licensing Agreement with Vegenics
- Intermune Inks New Supply Deal with Boehringer Ingelheim
- Boston Life Sciences Adopts New Name of Alseres Pharmaceuticals
- Cambrex Divests Bioproducts and Biopharma Subsidiaries
- Dragon Divests Epo Business
- Caregene and Genzyme Forms Partnership to Develop Cere-120
- Amgen Bags Ec Approval on Use of Aranesp(R) in Paediatric Patients
- Nsgene to Undertake Phase Ib Clinical Trial of Nsg0202
- Roche Receives European Approval for Neorecormon
- Bolder Receives Two U.S. Patents for Hematopoietic Factors
- Hospira Receives Ec Approval on Retacrit
- Rls to Initiate Clinical Trials of Erythropoietin
- Intermune Drops Phase Iii Trial of Interferon
- Chugai to Conduct Additional Trial on Epogin®
- 12.Major Players
- Amgen, Inc. (USA)
- Biomimetic Therapeutics, Inc. (USA)
- Biopharm Gmbh (Germany)
- Bolder Biotechnology, Inc. (USA)
- Alseres Pharmaceuticals, Inc. (USA)
- Ceregene, Inc. (USA)
- Fibrogen, Inc. (USA)
- Fziomed, Inc. (USA)
- Insmed, Inc. (USA)
- Johnson & Johnson (USA)
- Janssen-Ortho, Inc. (Canada)
- Lonza Group (Switzerland)
- Maxygen, Inc. (USA)
- Merck Serono International S.A. (Switzerland)
- Nsgene A/S (Denmark)
- Peprotech, Inc. (USA)
- Rentschler Biotechnologie Gmbh (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Chugai Pharmaceutical Co. Ltd. (Japan)
- Genentech, Inc. (USA)
- Shantha Biotechnics (India)
- Scil Proteins Gmbh (Germany)
- Wockhardt Ltd. (India)
- 13.Market Analytics
- 14.The United States
- Epo Market Scenario
- Key Market Driver for Epo
- Leading Epo Drugs in The US
- 15.Japan
- Erythropoietin Market: Competitive Scenario
- Leading Epo Drugs in Japan
- Market Scenario for Biotech Products
- Biotech Market Backed by Public Assistance
- 16.Europe
- 17.Rest of World
- An Overview of Indian Market
- Erythropoietin
- G-Csf Market
- Interferon59table 1: Global Growth Factors (Blood and Tissue) Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 2: Percentage Breakdown of Global Growth Factors (Blood and Tissue) Market by Region for The Years 2008 &
- Table 3: Global Blood Growth Factors Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 4: Percentage Breakdown of Global Blood Growth Factors Market by Region for The Years 2008 &
- Table 5: Global Blood Growth Factors Market by Type for The Period 2007-2015 (Sales in US$ Million)
- Table 6: Percentage Breakdown of Global Blood Growth Factors Market by Type for The Years 2008 &
- Table 7: Global Erythropoietins Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 8: Percentage Breakdown of Global Erythropoietins Market by Region for The Years 2008 &
- Table 9: Global Colony Stimulating Factors Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 10: Percentage Breakdown of Global Colony Stimulating Factors Market by Region for The Years 2008 &
- Table 11: Global Interferons Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 12: Percentage Breakdown of Global Interferons Market by Region for The Years 2008 &
- Table 13: Global Interleukins Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 14: Percentage Breakdown of Global Interleukins Market by Region for The Years 2008 &
- Table 15: Global Tissue Growth Factors Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 16: Percentage Breakdown of Global Tissue Growth Factors Market by Region for The Years 2008 &
- Table 17: Growth Factors (Blood and Tissue) Market by Type in The US: 2007-2015 (Sales in US$ Million)
- Table 18: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in The US for The Years 2008 &
- Table 19: Growth Factors (Blood and Tissue) Market by Type in Japan: 2007-2015 (Sales in US$ Million)
- Table 20: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in Japan for The Years 2008 &
- Table 21: Growth Factors (Blood and Tissue) Market by Type in Europe: 2007-2015 (Sales in US$ Million)
- Table 22: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in Europe for The Years 2008 &
- Table 23: Growth Factors (Blood and Tissue) Market by Type in The Rest of World: 2007-2015 (Sales in US$ Million)
- Table 24: Percentage Breakdown of Growth Factors (Blood and Tissue) Market by Type in The Rest of World for The Years 2008 &
- Companies Profiled